ATF6-related retinopathy
MONDO:0100447A retinopathy caused by biallelic variants in the AFT6 gene.
Also known as: ATF6 retinopathy, ATF6-related retinopathy, ACHM7, ATF6 achromatopsia, achromatopsia 7, achromatopsia caused by mutation in ATF6, achromatopsia type 7
34 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Could a liver drug help people see color? tiny trial launched
Symptom relief TerminatedThis early-phase trial tests whether an FDA-approved drug called glycerol phenylbutyrate (PBA) can improve vision in people with a rare form of color blindness caused by mutations in the ATF6 gene. Only 2 participants are enrolled, and they will take PBA three times daily while t…
Phase: EARLY_PHASE1 • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 26, 2026 15:34 UTC
-
Free eye tests aim to catch vision loss early in harlem and washington heights
Knowledge-focused OngoingThis study offers free vision screenings to underserved adults over 40 living in affordable housing in Harlem and Washington Heights. The goal is to find eye problems like glaucoma, cataracts, and diabetic retinopathy early and connect people with follow-up care. About 749 partic…
Phase: NA • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC